CNS Primary Tumor, Not Otherwise Specified (NOS): Clinical Trials

1 trial for CNS Primary Tumor, Not Otherwise Specified (NOS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow CNS Primary Tumor, Not Otherwise Specified (NOS): new trials by email Literature Review of CNS Primary Tumor, Not Otherwise Specified (NOS) trials Research Report on CNS Primary Tumor, Not Otherwise Specified (NOS)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
APX005M treatment for recurrent or refractory primary malignant CNS tumor patients, APX005M treatment for newly diagnosed DIPG patients - Glioblastoma Multiforme, High-grade Astrocytoma Not Otherwise Specified (NOS)
Phase 1CompletedPediatric Brain Tumor Consortium322018-03-012026-08-13

Narrower conditions

Ependymoma (1)  ·  Glioblastoma (1)  ·  Medulloblastoma (1)

Broader conditions

Astrocytoma (1)  ·  Glioma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroectodermal Tumors, Primitive (1)

Sponsors

Pediatric Brain Tumor Consortium (1)

Countries

United States (1)

Top investigators

Ira Dunkel (1)

NIH funding

UM1CA081457 (1)